PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sysmex Europe GmbH, Hamburg, Germany.\', \'Amphia Hospital, Breda, Netherlands.\', \'Elisabeth-Tweesteden Hospital, Tilburg, Netherlands.\', \'Hospital Papa Giovanni XXIII, Bergamo, Italy.\', \'Erasmus MC, University Medical Center, Rotterdam, Netherlands.\', \'Leiden University Medical Center, Leiden, Netherlands.\', \'Albert Schweitzer Hospital, Dordrecht, Netherlands.\', \'Canisius Wilhelmina Hospital, Nijmegen, Netherlands.\', \'Catharina Hospital, Eindhoven, Netherlands.\', \'University Hospital Antwerp, Antwerp, Belgium.\', \'University Medical Center Groningen, University of Groningen, Groningen, Netherlands.\', \'Zuyderland Medical Center, Sittard-Geleen, Netherlands.\', \'Radboud University Medical Center, Nijmegen, Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.63195e63195
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 33241996
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33241996>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33241996>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all